Fitz-Patrick D, Young M, Yacisin K, McElwee K, et al. Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults >/=65 years old. Vaccine 2023 May 8:S0264-410X(23)00520-0. doi: 10.1016/j.vaccine.2023.
PMID: 37244809